Immunity and tolerance to fungi in hematopoietic transplantation: Principles and perspectives

Frontiers in Immunology

Volumn 3, Issue JUN, 2012, Pages

  Carvalho, Agostinho ^a,b,c   Cunha, Cristina ^a   Bozza, Silvia ^a   Moretti, Silvia ^a   Massi Benedetti, Cristina ^a   Bistoni, Francesco ^a   Aversa, Franco ^d   Romani, Luigina ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF MINHO   (Portugal)

^c UNIVERSITY OF MINHO   (Portugal)

^d UNIVERSITY OF PARMA   (Italy)

Author keywords

Fungal infections; IDO; Resistance; Single nucleotide polymorphism; Tolerance

Indexed keywords

EID: 84874127793     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00156     Document Type: Article

References (68)

1. Albert, M. H., Anasetti, C., and Yu, X. Z. (2006). T regulatory cells as an immunotherapy for transplan-tation. Expert Opin. Biol. Ther. 6, 315-324.
2. Alegre, M. L., Leemans, J., Le Moine, A., Florquin, S., De Wilde,V., Chong,A., and Goldman, M. (2008). The multiple facets of toll-like receptors in transplantation biology. Transplan-tation 86, 1-9.
3. Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bach-mann, M. F., Larsen, C. P., and Ahmed, R. (2009). mTOR regulates memory CD8 T-cell differentiation. Nature 460, 108-112.
4. Arpinati, M., Chirumbolo, G., Urbini, B., Perrone, G., Rondelli, D., and Anasetti, C. (2003). Role of plas-macytoid dendritic cells in immu-nity and tolerance after allogeneic hematopoietic stem cell transplanta-tion. Transpl. Immunol. 11, 345-356.
5. Bianchi, M. E. (2007). DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81, 1-5.
6. Bonifazi, P., D'Angelo, C., Zagarella, S., Zelante, T., Bozza, S., De Luca, A., Giovannini, G., Moretti, S., Iannitti, R. G., Fallarino, F., Carvalho, A., Cunha, C. Bis-toni, F., and Romani, L. (2010). Intranasally delivered siRNA target-ing PI3K/Akt/mTOR inflammatory pathways protects from aspergillosis. Mucosal Immunol. 3, 193-205.
7. Bonifazi, P., Zelante, T., D'Angelo, C., De Luca, A., Moretti, S., Bozza, S., Perruccio,K.,Iannitti,R. G.,Giovan-nini, G., Volpi, C., Fallarino, F., Puc-cetti, P., and Romani, L. (2009). Bal-ancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans. Mucosal Immunol. 2, 362-374.
8. Bozza, S., Perruccio, K., Montag-noli, C., Gaziano, R., Bellocchio, S., Burchielli, E., Nkwanyuo, G., Pitzurra, L.,Velardi, A., and Romani, L. (2003). A dendritic cell vaccine against invasive aspergillosis in allo-geneic hematopoietic transplanta-tion. Blood 102, 3807-3814.
9. Brandacher, G., Margreiter, R., and Fuchs, D. (2008). Clinical relevance of indoleamine 2,3-dioxygenase for alloimmunity and transplantation. Curr. Opin. Organ Transplant. 13, 10-15.
10. Bretz, C., Gersuk, G., Knoblaugh, S., Chaudhary,N.,Randolph-Habecker, J., Hackman, R. C., Staab, J., and Marr, K. A. (2008). MyD88 signal-ing contributes to early pulmonary responses to Aspergillus fumigatus. Infect. Immun. 76, 952-958.
11. Carvalho, A., Cunha, C., Carotti, A., Aloisi, T., Guarrera, O., Di Ianni, M., Falzetti, F., Bistoni, F., Aversa, F., Pitzurra, L., Rodrigues, F., and Romani, L. (2009). Polymorphisms in Toll-like receptor genes and sus-ceptibility to infections in allo-geneic stem cell transplantation. Exp. Hematol. 37, 1022-1029.
12. Chen, L., Wang, T., Zhou, P., Ma, L., Yin, D., Shen, J., Molinero, L., Nozaki, T., Phillips, T., Uematsu, S., Akira, S., Wang, C. R., Fairchild, R. L., Alegre, M. L., and Chong, A. (2006). TLR engagement prevents transplanta-tion tolerance. Am. J. Transplant. 6, 2282-2291.
13. Cobbold, S. P., Adams, E., Nolan, K. F., Regateiro, F. S., and Waldmann, H. (2010). Connecting the mechanisms of T-cell regulation: dendritic cells as the missing link. Immunol. Rev. 236, 203-218.
14. Cunha, C., Aversa, F., Bistoni, G., Casagrande, A., Rodrigues, F., Romani, L., and Carvalho, A. (2011a). Immunogenetic profiling to predict risk of invasive fungal dis-eases: where are we now? Immunol. Invest. 40, 723-734.
15. Cunha, C., Giovannini, G., Pierini, A., Bell, A. S., Sorci, G., Riuzzi, F., Donato, R., Rodrigues, F.,Velardi,A., Aversa, F., Romani, L., and Carvalho, A. (2011b). Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients. PLoS ONE 6, e27962. doi:10.1371/jour-nal.pone.0027962
16. Cunha, C., Di Ianni, M., Bozza, S., Gio-vannini, G., Zagarella, S., Zelante, T., D'Angelo, C., Pierini, A., Pitzurra, L., Falzetti, F., Carotti, A., Perruccio, K., Latge, J. P., Rodrigues, F., Velardi, A., Aversa, F., Romani, L., and Car-valho, A. (2010). Dectin-1 Y238X polymorphism associates with sus-ceptibility to invasive aspergillo-sis in hematopoietic transplanta-tion through impairment of both recipient-and donor-dependent mechanisms of antifungal immu-nity. Blood 116, 5394-5402.
17. de Luca, A., Bozza, S., Zelante, T., Zagarella, S., D'Angelo, C., Per-ruccio, K., Vacca, C., Carvalho, A., Cunha, C., Aversa, F., and Romani, L. (2010). Non-hematopoietic cellscontributetoprotectivetol-erance to Aspergillus fumigatus via a TRIF pathway converging on IDO. Cell. Mol. Immunol. 7, 459-470.
18. De Luca, A., Montagnoli, C., Zelante, T., Bonifazi, P., Bozza, S., Moretti, S., D'Angelo, C., Vacca, C., Boon, L., Bistoni, F., Puccetti, P., Fallar-ino, F., and Romani, L. (2007). Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhi-bition of Rorc. J. Immunol. 179, 5999-6008.
19. Delgoffe, G. M., Kole, T. P., Zheng, Y., Zarek, P. E., Matthews, K. L., Xiao, B., Worley, P. F., Kozma, S. C., and Pow-ell, J. D. (2009). The mTOR kinase differentially regulates effector and regulatory T cell lineage commit-ment. Immunity 30, 832-844.
20. Desvignes, L., and Ernst, J. D. (2009). Interferon-gamma-responsive non-hematopoietic cells regulate the immune response to Mycobacterium tuberculosis. Immunity 31, 974-985.
21. Fugier-Vivier, I. J., Rezzoug, F., Huang, Y., Graul-Layman, A. J., Schanie, C. L., Xu, H., Chilton, P. M., and Ildstad, S. T. (2005). Plasmacy-toid precursor dendritic cells facil-itate allogeneic hematopoietic stem cell engraftment. J. Exp. Med. 201, 373-383.
22. Goldstein, A. L., and Badamchian, M. (2004). Thymosins: chemistry and biological properties in health and disease. Expert Opin. Biol. Ther. 4, 559-573.
23. Grow, W. B., Moreb, J. S., Roque, D., Manion, K., Leather, H., Reddy, V., Khan, S. A., Finiewicz, K. J., Nguyen, H., Clancy, C. J., Mehta, P. S., and Wingard, J. R. (2002). Late onset of invasive Aspergillus infection in bone marrow transplant patients at a university hospital. Bone Marrow Transplant. 29, 15-19.
24. Gupta, A. O., and Singh, N. (2011). Immune reconstitution syndrome and fungal infections. Curr. Opin. Infect. Dis. 24, 527-533.
25. Hainz, U., Jurgens, B., Wekerle, T., Seidel, M. G., and Heitger, A. (2007). Indoleamine 2,3-dioxygenase in hematopoietic stem cell trans-plantation. Curr.DrugMetab.8, 267-272.
26. Holland, S. M., Deleo, F. R., Elloumi, H. Z., Hsu, A. P., Uzel, G., Brod-sky, N., Freeman, A. F., Demidowich, A., Davis, J., Turner, M. L., Ander-son, V. L., Darnell, D. N., Welch, P. A., Kuhns, D. B., Frucht, D. M., Malech,H. L.,Gallin,J. I.,Kobayashi, S. D., Whitney, A. R., Voyich, J. M., Musser, J. M., Woellner, C., Schaffer, A. A., Puck, J. M., and Grimbacher, B. (2007). STAT3 mutations in the hyper-IgE syndrome. N.Engl.J.Med. 357, 1608-1619.
27. Jiang, S., and Lombardi, G. (2006). New trends in immunosup-pression and immunotherapy. Int. Immunopharmacol. 6, 1874-1878.
28. Kabelitz,D.,Wesch,D.,and Oberg,H. H. (2006). Regulation of regulatory T cells: role of dendritic cells and toll-like receptors. Crit. Rev. Immunol. 26, 291-306.
29. Land, W. G. (2007). Innate immunity-mediated allograft rejection and strategies to prevent it. Transplant. Proc. 39, 667-672.
30. Larosa, D. F., Rahman, A. H., and Turka, L. A. (2007). The innate immune system in allograft rejec-tion and tolerance. J. Immunol. 178, 7503-7509.
31. Marr, K. A., Carter, R. A., Boeckh, M., Martin, P., and Corey, L. (2002). Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiol-ogy and risk factors. Blood 100, 4358-4366.
32. Martinic,M. M.,and von Herrath,M. G. (2006). Control of graft-versus-host disease by regulatory T cells: which level of antigen specificity? Eur. J. Immunol. 36, 2299-2303.
33. Mason, D. (1998). A very high level of crossreactivity is an essential fea-ture of the T-cell receptor. Immunol. Today 19, 395-404.
34. Matsuoka, K., Kim, H. T., Mcdonough, S., Bascug, G.,Warshauer, B., Koreth, J., Cutler, C., Ho, V. T., Alyea, E. P., Antin, J. H., Soiffer, R. J., and Ritz, J. (2010). Altered regula-tory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation. J. Clin. Invest. 120, 1479-1493.
35. Medzhitov, R., Schneider, D. S., and Soares, M. P. (2012). Disease toler-ance as a defense strategy. Science 335, 936-941.
36. Mellor, A. L., and Munn, D. H. (2008). Creating immune privilege: active local suppression that benefits friends, but protects foes. Nat. Rev. Immunol. 8, 74-80.
37. Mezger, M., Einsele, H., and Loef-fler, J. (2010). Genetic susceptibil-ity to infections with Aspergillus fumigatus. Crit. Rev. Microbiol. 36, 168-177.
38. Montagnoli, C., Fallarino, F., Gaziano, R., Bozza, S., Bellocchio, S., Zelante, T., Kurup, W. P., Pitzurra, L., Puccetti, P., and Romani, L. (2006). Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism. J. Immunol. 176, 1712-1723.
39. Mori, S., Kocak, U., Shaw, J. L., and Mullen, C. A. (2005). Aug-mentation of post transplant immunity: antigen encounter at the time of hematopoietic stem cell transplantation enhances antigen-specific donor T-cell responses in the post transplant repertoire. Bone Marrow Transplant. 35, 793-801.
40. Mulanovich, V. E., and Kontoyiannis, D. P. (2011). Fungal pneumonia in patients with hematologic malig-nancies: current approach and man-agement. Curr. Opin. Infect. Dis. 24, 323-332.
41. Ortega, M., Rovira, M., Filella, X., Martinez, J. A., Almela, M., Puig, J., Carreras, E., and Mensa, J. (2006). Prospective evaluation of procalcitonin in adults with non-neutropenic fever after allogeneic hematopoietic stem cell transplan-tation. Bone Marrow Transplant. 37, 499-502.
42. Pallotta, M. T., Orabona, C., Volpi, C., Vacca, C., Belladonna, M. L., Bianchi, R., Servillo, G., Brunacci, C., Calvitti, M., Bicciato, S., Mazza, E. M., Boon, L., Grassi, F., Fioretti, M. C., Fallarino, F., Puccetti, P., and Grohmann, U. (2011). Indoleamine 2,3-dioxygenase is a signaling pro-tein in long-term tolerance by dendritic cells. Nat. Immunol. 12, 870-878.
43. Paveglio, S. A., Allard, J., Foster Hodgkins, S. R., Ather, J. L., Beve-lander, M., Campbell, J. M., Whit-taker Leclair, L. A., Mccarthy, S. M., Van Der Vliet, A., Suratt, B. T., Boyson, J. E., Uematsu, S., Akira, S., and Poynter, M. E. (2011). Airway epithelial indoleamine 2,3-dioxygenase inhibits CD4+ T cells during Aspergillus fumigatus antigen exposure. Am. J. Respir. Cell Mol. Biol. 44, 11-23.
44. Peter, C., Waldmann, H., and Cobbold, S. P. (2010). mTOR signalling and metabolic regulation of T cell differ-entiation. Curr. Opin. Immunol. 22, 655-661.
45. Puccetti, P., and Grohmann, U. (2007). IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB acti-vation. Nat. Rev. Immunol. 7, 817-823.
46. Read, A. F., Graham, A. L., and Raberg, L. (2008). Animal defenses against infectious agents: is dam-age control more important than pathogen control. PLoS Biol. 6, e4. doi:10.1371/journal.pbio.1000004
47. Reddy, V., Iturraspe, J. A., Tzo-las, A. C., Meier-Kriesche, H. U., Schold, J., and Wingard, J. R. (2004). Low dendritic cell count after allogeneic hematopoi-etic stem cell transplantation pre-dicts relapse, death, and acute graft-versus-host disease. Blood 103, 4330-4335.
48. Restif, O., and Koella, J. C. (2004). Con-current evolution of resistance and tolerance to pathogens. Am. Nat. 164, E90-E102.
49. Romani, L. (2011). Immunity to fun-gal infections. Nat. Rev. Immunol. 11, 275-288.
50. Romani, L., Bistoni, F., Perruccio, K., Montagnoli, C., Gaziano, R., Bozza, S., Bonifazi, P., Bistoni, G., Rasi, G., Velardi, A., Fallarino, F., Garaci, E., and Puccetti, P. (2006). Thymosin alpha1 activates den-dritic cell tryptophan catabolism and establishes a regulatory envi-ronment for balance of inflam-mation and tolerance. Blood 108, 2265-2274.
51. Romani, L., Fallarino, F., De Luca, A., Montagnoli, C., D'Angelo, C., Zelante, T., Vacca, C., Bistoni, F., Fioretti, M. C., Grohmann, U., Segal, B. H., and Puccetti, P. (2008a). Defective tryp-tophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451, 211-215.
52. Romani, L., Zelante, T., De Luca, A., Fallarino, F., and Puccetti, P. (2008b). IL-17 and therapeutic kynurenines in pathogenic inflam-mation to fungi. J. Immunol. 180, 5157-5162.
53. Romani, L., and Puccetti, P. (2007). Controlling patho-genic inflammation to fungi. Expert Rev. Anti. Infect. Ther. 5, 1007-1017.
54. Rosentul, D. C., Plantinga, T. S., Oost-ing, M., Scott, W. K., Velez Edwards, D. R., Smith, P. B., Alexander, B. D., Yang, J. C., Laird, G. M., Joosten, L. A., Van Der Meer, J. W., Perfect, J. R., Kullberg, B. J., Netea, M. G., and Johnson, M. D. (2011). Genetic vari-ation in the dectin-1/CARD9 recog-nition pathway and susceptibility to candidemia. J. Infect. Dis. 204, 1138-1145.
55. Saemann, M. D., Haidinger, M., Heck-ing, M., Horl, W. H., and Weich-hart, T. (2009). The multifunc-tional role of mTOR in innate immunity: implications for trans-plant immunity. Am. J. Transplant. 9, 2655-2661.
56. Santamaria, R., Rizzetto, L., Bromley, M., Zelante, T., Lee, W., Cavalieri, D., Romani, L., Miller, B., Gut, I., Santos, M., Pierre, P., Bowyer, P., and Kapushesky, M. (2011). Systems biology of infectious diseases:a focus on fungal infections. Immunobiology 216, 1212-1227.
57. Saraiva,M.,and O'Garra,A. (2010). The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10, 170-181.
58. Schneider, D. S., and Ayres, J. S. (2008). Two ways to survive infec-tion: what resistance and tolerance can teach us about treating infec-tious diseases. Nat. Rev. Immunol. 8, 889-895.
59. Schubert, M. S. (2006). Allergic fungal sinusitis. Clin. Rev. Allergy Immunol. 30, 205-216.
60. Simitsopoulou, M., Roilides, E., and Walsh, T. J. (2011). Immunomod-ulatory properties of antifungal agents on phagocytic cells. Immunol. Invest. 40, 809-824.
61. Singh, N., and Perfect, J. R. (2007). Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect. Dis. 7, 395-401.
62. Sorci, G., Giovannini, G., Riuzzi, F., Bonifazi, P., Zelante, T., Zagarella, S., Bistoni, F., Donato, R., and Romani, L. (2011). The danger signal S100B integrates pathogen-and danger-sensing pathways to restrain inflam-mation. PLoS Pathog. 7, e1001315. doi:10.1371/journal.ppat.1001315
63. Turnquist, H. R., and Thomson, A. W. (2008). Taming the lions: manipulating dendritic cells for use as negative cellular vaccines in organ transplantation. Curr. Opin. Organ Transplant. 13, 350-357.
64. Waldmann, H., and Cobbold, S. (2004). Exploiting tolerance processes in transplantation. Science 305, 209-212.
65. Werner, J. L., Metz, A. E., Horn, D., Schoeb, T. R., Hewitt, M. M., Schwiebert, L. M., Faro-Trindade, I., Brown, G. D., and Steele, C. (2009). Requisite role for the dectin-1 beta-glucan receptor in pul-monary defense against Aspergillus fumigatus. J. Immunol. 182, 4938-4946.
66. Zelante, T., De Luca, A., Bonifazi, P., Montagnoli, C., Bozza, S., Moretti, S., Belladonna, M. L., Vacca, C., Conte, C., Mosci, P., Bistoni, F., Puccetti, P., Kastelein, R. A., Kopf, M., and Romani, L. (2007). IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur. J. Immunol. 37, 2695-2706.
67. Zelante, T., Iannitti, R. G., De Luca, A., Arroyo, J., Blanco, N., Servillo, G., Sanglard, D., Reichard, U., Palmer, G. E., Latge, J. P., Puccetti, P., and Romani, L. (2012). Sensing of mammalian IL-17A regulates fungal adaptation and virulence. Nat. Com-mun. 3, 683.
68. Zuber, J., Hermine, O., Chatenoud, L., and Legendre, C. (2011). Harness-ing regulatory T cells for transplant tolerance in the clinic through mTOR inhibition: myth or reality? Curr. Opin. Organ Transplant. 16, 606-613.